Elevance Health Inc. ELV
NYSE · Healthcare · Medical - Healthcare Plans
$394.48
Close on Fri, 20 Nov 2026 · market value $85.2B
What the price is betting on
Below its recordAt $394, the price assumes revenue shrinks about 13% a year for five years, from $202B to about $109B by FY2030. That is less than what analysts expect for the next two years and less than the company's own last three years.
Revenue growth a year. The price figure comes from a reverse DCF at a 8% discount rate.
Track it and Parra checks each report against the path, and tells you when revenue falls behind it.
Own more than ELV? Check up to 5 of your stocks at once, free, no account.
Both sides
Three stories, three values
Bear
$671
Base
$733
Bull
$801
Today $394
- Bear $671. Cash flow grows 0% a year for the next 5 years, slower than expected, then slows to long-run growth.
- Base $733. Cash flow grows 2% a year for the next 5 years, as analysts expect, then slows to long-run growth.
- Bull $801. Cash flow grows 4% a year for the next 5 years, faster than expected, then slows to long-run growth.
Stories set by rules from the company’s record.
Checkpoints
The revenue the price needs
- YearNeedsAnalysts expect
- FY2026$195B$200B, on the path
- FY2027$169B$205B, on the path
- FY2028$146B$213B, on the path
- FY2029$126B$217B, on the path
- FY2030$109B$238B, on the path
Each year's revenue at −13% growth from $202B in the 12 months to September 2026.
At a glance
Healthcare · Medical - Healthcare Plans · listed on NYSE
- Revenue, FY2025
- $199B
- Growth, 3 years a year
- 6.1%
- Cash margin
- 1.6%
- Net debt
- $23.7B
- Shares, 3-year change
- −8.6%
- Dividend yield
- 1.8%
What other healthcare prices are betting on
Figures from company filings and end-of-day market data, as of the close on Fri, 20 Nov 2026; updated every trading day. This page shows what today's price assumes, not whether to buy or sell. Not investment advice.